ANIX

Anixa Biosciences (ANIX)

Anixa Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ANIX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/22	22:15	PR Newswire (US)	Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset	NASDAQ:ANIX	Anixa Biosciences Inc
2024/11/18	22:20	PR Newswire (US)	Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
2024/11/09	03:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANIX	Anixa Biosciences Inc
2024/11/09	03:17	PR Newswire (US)	Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting	NASDAQ:ANIX	Anixa Biosciences Inc
2024/11/06	22:30	PR Newswire (US)	Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting	NASDAQ:ANIX	Anixa Biosciences Inc
2024/10/31	21:15	PR Newswire (US)	Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024	NASDAQ:ANIX	Anixa Biosciences Inc
2024/10/28	21:30	PR Newswire (US)	Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting	NASDAQ:ANIX	Anixa Biosciences Inc
2024/10/24	00:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/10/15	22:00	PR Newswire (US)	Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
2024/10/07	21:30	PR Newswire (US)	Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development	NASDAQ:ANIX	Anixa Biosciences Inc
2024/09/30	21:30	PR Newswire (US)	Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial	NASDAQ:ANIX	Anixa Biosciences Inc
2024/09/24	21:30	PR Newswire (US)	Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine	NASDAQ:ANIX	Anixa Biosciences Inc
2024/09/18	21:30	PR Newswire (US)	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference	NASDAQ:ANIX	Anixa Biosciences Inc
2024/09/07	06:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ANIX	Anixa Biosciences Inc
2024/09/03	21:30	PR Newswire (US)	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium	NASDAQ:ANIX	Anixa Biosciences Inc
2024/08/26	21:30	PR Newswire (US)	Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:ANIX	Anixa Biosciences Inc
2024/08/02	01:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/07/29	21:45	PR Newswire (US)	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting	NASDAQ:ANIX	Anixa Biosciences Inc
2024/07/29	19:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/07/27	02:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/07/23	21:15	PR Newswire (US)	Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy	NASDAQ:ANIX	Anixa Biosciences Inc
2024/07/17	21:00	PR Newswire (US)	Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology	NASDAQ:ANIX	Anixa Biosciences Inc
2024/07/15	21:30	PR Newswire (US)	Anixa Biosciences Announces $5 Million Share Repurchase Program	NASDAQ:ANIX	Anixa Biosciences Inc
2024/06/24	21:45	PR Newswire (US)	Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
2024/06/18	22:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/06/14	22:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/06/13	00:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/06/10	23:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/06/08	01:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
2024/06/07	23:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc